BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Jul 18, 2025

BHIC Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
4442368--
Market Cap Growth
-88.28%-88.55%---
Enterprise Value
4342368--
Last Close Price
1.001.009.018.003.75
PE Ratio
75.05483.87---
PS Ratio
15.7222.82615.03--
PB Ratio
34.8050.40-54370.02--
P/TBV Ratio
36.4252.02---
P/OCF Ratio
109.921815.43---
EV/Sales Ratio
15.3622.66615.10--
EV/EBIT Ratio
75.70480.43---
Debt / Equity Ratio
0.04--12.88-2.64-1.10
Asset Turnover
3.613.829.564.37-
Inventory Turnover
6.4411.174.53--
Quick Ratio
8.4420.350.560.400.09
Current Ratio
10.0721.990.930.650.09
Return on Equity (ROE)
82.38%21.00%---
Return on Assets (ROA)
45.75%11.24%-251.51%-442.83%-
Return on Capital (ROIC)
48.68%11.88%-289.79%-496.65%-
Return on Capital Employed (ROCE)
44.90%10.40%---
Earnings Yield
1.29%0.21%-0.07%--
Buyback Yield / Dilution
-6.01%-25.44%-301.99%-147.38%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.